Duration of cooling: 72 hours at 34°C–35°C (measured rectally). Followed up infants until 18 months of age with neurologic, visual, auditory, and neurodevelopmental assessments by a ...

umcutrecht.nl Outcome of full-term infants with neonatal encephalopathy of hypoxic-ischemic origin is often assessed in ... assessment into childhood in children with and without adverse neurological ...

Objective To evaluate the neuroprotective effect of therapeutic hypothermia (TH) induced by phase changing material (PCM) on MRI biomarkers in infants with hypoxic-ischaemic encephalopathy ... every 6 ...

Erythropoietin, a treatment for newborns with critically low levels of oxygen or blood supply to the brain at birth, does not prevent death or disability, according to a new multinational study.

Hypoxic-ischemic encephalopathy is a leading cause of death and disability among newborns, and the search for ways to prevent, detect, and treat it remains critical." Helen G. Liley, MBChB ...

Liley HG, et al. Aiming to prevent adverse outcomes of neonatal hypoxic ischemic encephalopathy with erythropoietin — the PAEAN multicenter randomized controlled trial. Presented at: Pediatric ...

The Company’s lead candidate, RLS-0071 (pegtarazimod), has received FDA Orphan Drug Designation and Fast Track Designations for hypoxic ischemic encephalopathy (HIE), a devastating disease that ...

This exam is essential in diagnosing neurological conditions such as stroke, multiple sclerosis, peripheral neuropathy, or spinal cord lesions. Dr Karan Posted: April 15, 2025 | Last updated ...

Over the last two decades, significant progress has been made in the management of neonatal encephalopathy due to presumed hypoxic-ischemic encephalopathy. One key area that requires improvement is ...